Skip to content

Insider · CIK 0001809482

Lou Basenese

director

Files at CLIR (ClearSign Technologies Corp), NDRA (ENDRA Life Sciences Inc.). First filing -, latest -.

In brief

Lou Basenese files SEC Form 4 as director at CLIR (ClearSign Technologies Corp), and also at NDRA (ENDRA Life Sciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Lou Basenese has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026CLIR
ClearSign Technologies Corp
AGrant or award
Non-Statutory Stock Optionsderivative
+3,766$0.00$03,76611 d ago
Jun 30, 2026CLIR
ClearSign Technologies Corp
AGrant or award
Non-Statutory Stock Optionsderivative
+4,595$0.00$04,595Jul 2, 2026
Mar 31, 2026CLIR
ClearSign Technologies Corp
AGrant or award
Non-Statutory Stock Optionsderivative
+3,024$0.00$03,024Apr 2, 2026
Jan 21, 2026NDRA
ENDRA Life Sciences Inc.
AGrant or award
Common Stock
+60,324$0.00$065,709Jan 23, 2026
Oct 1, 2025CLIR
ClearSign Technologies Corp
AGrant or award
Restricted Stock Unitsderivative
+24,621$0.00$070,266Oct 3, 2025
Jul 1, 2025CLIR
ClearSign Technologies Corp
AGrant or award
Restricted Stock Unitsderivative
+34,722$0.00$045,645Jul 3, 2025
Jun 11, 2025NDRA
ENDRA Life Sciences Inc.
AGrant or award
Common Stock
+5,384$0.00$05,385Jul 1, 2025
May 22, 2025CLIR
ClearSign Technologies Corp
AGrant or award
Restricted Stock Unitsderivative
+10,923$0.00$010,923May 27, 2025

Questions about Lou Basenese

Answered from the filings on this page, as of the latest one.

Is Lou Basenese buying or selling?

Lou Basenese has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Lou Basenese's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lou Basenese has 0.

Where does Lou Basenese file Form 4?

Lou Basenese has filed Form 4 at CLIR (ClearSign Technologies Corp); NDRA (ENDRA Life Sciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Lou Basenese: insider trades and track record | InsiderTell